secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0000950170-24-102338
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CFO Mark Austin departs; separation agreement provides $138K severance and COBRA subsidy
--------------------------------------------------------------------------------

- Mark Austin ceased as executive officer and co-principal financial officer on Aug 16, 2024.
- Separation agreement finalized Aug 26, 2024; Austin remains strategic advisor through Aug 30, 2024.
- Severance includes $138,360.75 (6 months base salary) and $7,686.54 for COBRA coverage.
- Payments conditional on signing release and compliance with separation terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000095017024102338/0000950170-24-102338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000095017024102338/catx-20240826.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-102338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer